Circulating Biomarkers for Tumor Angiogenesis: Where Are We?

Curr Med Chem. 2020;27(14):2361-2380. doi: 10.2174/0929867325666180821151409.

Abstract

Background: In recent years, several anti-angiogenic drugs have been developed and their addition to standard treatment has been associated with clinical benefits. However, the response to anti-angiogenic therapy is characterized by considerable variability. In this context, the development of dynamic non-invasive biomarkers would be helpful to elucidate the emergence of anti-angiogenic resistance as well as to correctly address the treatment.

Objectives: The purpose of this review is to describe current reports on circulating diagnostic and prognostic biomarkers related to angiogenesis. We further discuss how this non-invasive strategy could improve the monitoring of tumor treatment and help clinical strategy.

Results: We discuss the latest evidence in the literature regarding circulating anti-angiogenic markers. Besides growth factor proteins, different circulating miRNAs could exert a pro- or anti-angiogenic activity so as to represent suitable candidates for a non-invasive strategy. Recent reports indicate that tumor-derived exosomes, which are small membrane vesicles abundant in biological fluids, also have an impact on vascular remodeling.

Conclusion: Numerous circulating biomarkers related to angiogenesis have been recently identified. Their use will allow identifying patients who are more likely to benefit from a specific anti-angiogenic treatment, as well as detecting those who will develop resistance and/or adverse effects. Nonetheless, further studies are required to elucidate the role of these biomarkers in clinical settings.

Keywords: Biomarkers; anti-angiogenic therapy; exosomes; micro-RNAs; proteins; tumor angiogenesis..

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors
  • Biomarkers
  • Biomarkers, Tumor
  • Humans
  • Immunotherapy
  • Neoplasms*
  • Neovascularization, Pathologic

Substances

  • Angiogenesis Inhibitors
  • Biomarkers
  • Biomarkers, Tumor